8-K
filed April 5, 2022, 7:59 PM ET
ticker LAB
CIK 0001162194
other material
confidence high
sentiment neutral
materiality 0.90
Fluidigm closes $225M convertible preferred financing, renames to Standard BioTools, appoints new CEO and board
STANDARD BIOTOOLS INC.
- Closed $225M private placement of Series B convertible preferred to Casdin and Viking (112,500 shares each at $1,000/share).
- Name changed from Fluidigm to Standard BioTools; authorized common shares doubled to 400M.
- Appointed Michael Egholm as CEO/President and Hanjoon Alex Kim as COO; former CEO Linthwaite resigned.
- Board expanded to 8; new directors: Eli Casdin, Martin Madaus, Frank Witney, and Michael Egholm.
- Adopted 2022 Inducement Plan reserving 9.5M shares; granted Egholm options for 4.5M shares and Kim 1.6M shares at $3.99.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Egholm was appointed as Director at STANDARD BIOTOOLS INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board also appointed Michael Egholm as a Class I director
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Martin Madaus was appointed as Director at STANDARD BIOTOOLS INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
Viking has designated Martin Madaus as the Series B-2 Director and, accordingly, effective as of the Closing Date, the Board has appointed Dr. Madaus
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Stephen Christopher Linthwaite resigned as Director at STANDARD BIOTOOLS INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
Stephen Christopher Linthwaite, Ana K. Stankovic and Nicolas M. Barthelemy each resigned from the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Eli Casdin was appointed as Director at STANDARD BIOTOOLS INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
Casdin has designated Eli Casdin as the Series B-1 Director and, accordingly, effective as of the Closing Date, the Board has appointed Mr. Casdin to serve as the Series B-1 Director
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Frank Witney was appointed as Director at STANDARD BIOTOOLS INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the Board also appointed Dr. Frank Witney to the Board to serve as a Class III director
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ana K. Stankovic resigned as Director at STANDARD BIOTOOLS INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
Stephen Christopher Linthwaite, Ana K. Stankovic and Nicolas M. Barthelemy each resigned from the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Nicolas M. Barthelemy resigned as Director at STANDARD BIOTOOLS INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
Stephen Christopher Linthwaite, Ana K. Stankovic and Nicolas M. Barthelemy each resigned from the Board
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.